Malin Life Sciences Holdings Ltd - Net Worth and Insider Trading
Malin Life Sciences Holdings Ltd Net Worth
The estimated net worth of Malin Life Sciences Holdings Ltd is at least $113 Million dollars as of 2024-12-26. Malin Life Sciences Holdings Ltd is the 10% Owner of Poseida Therapeutics Inc and owns about 11,835,673 shares of Poseida Therapeutics Inc (PSTX) stock worth over $113 Million. Malin Life Sciences Holdings Ltd is also the 10% Owner of NVN Liquidation Inc and owns about 259,849 shares of NVN Liquidation Inc (NOVNQ) stock worth over $0. Details can be seen in Malin Life Sciences Holdings Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Malin Life Sciences Holdings Ltd has not made any transactions after 2022-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Malin Life Sciences Holdings Ltd
Malin Life Sciences Holdings Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Malin Life Sciences Holdings Ltd owns 2 companies in total, including Poseida Therapeutics Inc (PSTX) , and NVN Liquidation Inc (NOVNQ) .
Insider Ownership Summary of Malin Life Sciences Holdings Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2022-08-08 | 10 percent owner |
| NOVNQ | NVN Liquidation Inc | 2019-07-02 | 10 percent owner |
Malin Life Sciences Holdings Ltd Latest Holdings Summary
Malin Life Sciences Holdings Ltd currently owns a total of 2 stocks. Among these stocks, Malin Life Sciences Holdings Ltd owns 11,835,673 shares of Poseida Therapeutics Inc (PSTX) as of August 8, 2022, with a value of $113 Million and a weighting of 100%. Malin Life Sciences Holdings Ltd also owns 259,849 shares of NVN Liquidation Inc (NOVNQ) as of July 2, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Malin Life Sciences Holdings Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2022-08-08 | 11,835,673 | 9.51 | 112,557,250 |
| NOVNQ | NVN Liquidation Inc | 2019-07-02 | 259,849 | 0.00 | 0 |
Holding Weightings of Malin Life Sciences Holdings Ltd
Malin Life Sciences Holdings Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Malin Life Sciences Holdings Ltd has made a total of 6 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Poseida Therapeutics Inc is the acquisition of 2,150,000 shares on August 8, 2022, which cost Malin Life Sciences Holdings Ltd around $8 Million.
According to the SEC Form 4 filings, Malin Life Sciences Holdings Ltd has made a total of 0 transactions in NVN Liquidation Inc (NOVNQ) over the past 5 years. The most-recent trade in NVN Liquidation Inc is the sale of 2,500 shares on July 2, 2019, which brought Malin Life Sciences Holdings Ltd around $67,750.
Insider Trading History of Malin Life Sciences Holdings Ltd
- 1
Malin Life Sciences Holdings Ltd Trading Performance
GuruFocus tracks the stock performance after each of Malin Life Sciences Holdings Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Malin Life Sciences Holdings Ltd is -29.18%. GuruFocus also compares Malin Life Sciences Holdings Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Malin Life Sciences Holdings Ltd within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Malin Life Sciences Holdings Ltd's insider trading performs compared to the benchmark.
Performance of Malin Life Sciences Holdings Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.81 | | | | | |
| Relative Return to S&P 500(%) | -2.49 | | | | | |
Malin Life Sciences Holdings Ltd Ownership Network
Malin Life Sciences Holdings Ltd Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
Malin Life Sciences Holdings Ltd is the 10 percent owner of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include director & President and CBO Mark J Gergen , President & Cell Therapy Kristin Yarema , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
Over the past 18 months, Malin Life Sciences Holdings Ltd made no insider transaction in Poseida Therapeutics Inc (PSTX). Other recent insider transactions involving Poseida Therapeutics Inc (PSTX) include a net sale of 60,000 shares made by Mark J Gergen ,
In summary, during the past 3 months, insiders sold 60,000 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 60,000 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,000 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
Malin Life Sciences Holdings Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Malin Life Sciences Holdings Ltd. You might contact Malin Life Sciences Holdings Ltd via mailing address: 2 Harbour Square, Crofton Road, Dun Laoghaire, Co, Dublin L2 ----.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
